Consenso - Associação Brasileira de Alergia e Imunopatologia

More documents

Recommendations

Info

56 Rev. bras. alerg. imunopatol. – Vol. 29, Nº 1, 2006 Consenso Lumry WR. A review of the preclinical and clinical data of 81. intranasal steroids used in the treatment of allergic newer J Allergy Clin Immunol 1999;104:150-8. rhinitis. Lund VJ, Black JH, Szabo LZ, Schrewelius C, Akerlund A. Effi- 82. and tolerability of budesonide aqueous nasal spray in cacy rhinosinusitis patients. Rhinology 2004; 42: 57-62. chronic Malm L, Anggard A. Vasoconstrictors. in: Mygind, N, Naclerio 83. (ed). Allergic and Non-Allergic Rhinitis. Clinical Aspects. RM Munksgaard, 1993; 95-100. Copenhagen: Maynard LM, Ernst ME. Leukotriene Receptor Antagonists in 84. treatment of Allergic Rhinitis. Ann Pharmacother 2001; the 35:1274-7. Mello Jr JF, Mion O. Rinite Alérgica. In: Campos, C. A. H.; 85. HOO. Tratado de Otorrinolaringologia. Editora Roca. Costa, p. 68-81. 2003; Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, 86. RA et al.Rhinosinusitis: Establishing definitions for Nicklas research and patient care. J Allergy Clin Immunol clinical 114: S155-S212. 2004; Meltzer EO, Orgel HA, Jalowayski AA. Histamine levels and 87. cytology in children with chronic otitis media and nasal Ann Allergy Asthma Immunol 1995; 74: 406-10. rhinitis. Meltzer EO. Clinical evidence for antileukotriene therapy in 88. management of allergic rhinitis. Ann Allergy Asthma Im- the 2002; 88: 23 -9. munol Menon AD, Stamm AC. In: Microcirurgia Nasosinusal. Stamm 89. Rio de janeiro: Editora Revista Ltda, 1995. AC. Micheletto C, Tognella S, Visconti M, Pomari C, Trevisan F, 90. Negro RW. Montelukast 10mg improves nasal function Del nasal response to aspirin in ASA sensitive asthmatics: a and study versus placebo. Allergy 2004; 59: 289-94. controlled Miyake MAM. Rinossinusopatia Alérgica. In: Stamm AC. Mi- 91. Nasossinusal. Rio de Janeiro: Revinter 1995; 129- crocirurgia 138. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen 92. al. Pollen immunotherapy reduces the development of L,et in children with seasonal rhinocon-junctivitis (the asthma J Allergy Clin Immunol 2002;109: 251-6. PAT-study). Moloney JR, Collins J. Nasal Polyps and Bronchial Asthma. Br 93. AlIergy Dis Chest 1997; 71:1. J Moneret-Valtrin DA, Shieh V, Wayoff M. Non-Allergic Rhinitis 94. Eosinophilia Syndrome (NARES) - A Precursor of the with Ann Allergy 1990; 64: 513-18. Triad. Montealegre F, Meyer B, Chardon D, Vargas W, Zavala D, 95. B, et al. Comparative prevalence of sensitization to Hart animal, plant and mould allergens in subjects with common or atopic dermatitis and/or allergic rhinitis living in a asthma, environment Clin Exp Allergy. 2004 Jan;34(1):51-8. tropical Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, 96. B. Comprehensive evaluation of cetirizine in the ma- Kramer of seasonal allergic rhinitis: impact on symptoms, nagement of life, productivity, and activity impairment. Allergy quality Proc 2002; 23: 391-8. Asthma Naclerio R, Rosenwasser L, Ohkubo K. Allergic rhinitis: cur- 97. and future treatments. Clin Exp Allergy Rev 2002; 2: rent 137-147. Naspitz CK, Solé D, Jacob CA, Sarinho E, Soares FJ, Dantas V 98. al. Sensitization to inhalant and food allergens in Brazilian et children by in vitro total and specific IgE assay. J Pe- atopic (Rio J) 2004; 80: 203-10. diatr Nassar J, Anselmo-Lima WT. Participação das variações ana- 99. do complexo ostiomeatal analisadas por tomografia tômicas Rev Bras ORL 2001; 67: 489-95. computadorizada. Nayak A. A review of montelukast in the treatment of asthma 100. allergic rhinitis. Expert Opin Pharmacother 2004; 5: 679- and 686. Nelson HS. Advances in upper airway diseases and allergen 101. J Allergy Clin Immunol 2004; 113: 635-42. immunotherapy. Nelson HS. Immunotherapy: 1999-2004. J Allergy Clin Im- 102. 2004; 113: 1013-23. munol Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW et al. 103. nervous system side effects of first and second gene- Central antihistamines in school children with perennial allergic ration a randomized, double-blind, placebo-controlled com- rhinitis: study. Pediatrics 2004; 113: 116-21. parative Nguyen LH, Manoukian JJ, Sobol SE, Tewfik Tl, Mazer BD, 104. MD et al. Similar allergic inflammation in the middle Schloss and the upper airway: evidence linking otitis media with ear to the united airways concept. J Allergy Clin Immu- effusion 2004; 114: 1110-5. nol. Nickel R, Illi S, Lau S, Sommerfeld C, Bergmann R, Kamin W, 105. al. Variability of total serum immunoglobulin E levels from et to the age of 10 years. A prospective evaluation in a birth birth cohort (German Multicenter Allergy Study) Clin large Allergy 2005; 35: 619-23. Exp Norjavaara E, De Verdier MG. Normal pregnancy outcomes in 106. population-based study including 2,968 pregnant women a to budesonide. J Allergy Clin Immunol 2003; 111: exposed 42. 736- Norman P.S. Sublingual swallow immunotherapy in the new 107. Ann Allergy Asthma Immunol 2004; 93: 405-6. world. Nunes ICC, Solé D, Pastorino AC, Melo K, Gonzáles C, Wan- 108. N, et al. Prevalence of asthma, rhino-conjunctivitis, dalsen atopic eczema among schoolchildren living in the state of and Paulo, Brazil - ISAAC phase III. J Allergy Clin Immunol São 113: S284. 2004; Oldenbeuving NB, Kleinjan A, Mulder PG, Lumley P, Groot EJ, 109. CM et al. Evaluation of an intranasal house dust mite Drunen model as a tool in clinical research. Allergy 2005; provocation 751-9. 60: Passáli D, Moesges R, Hassen HA, Belussi, L. International 110. on Allergic- Rhinitis in Childhood. Allergy 1999: Conference (suppl. 55): 10. 54 Pawankar R. Exploring the role of leukotriene receptor anta- 111. in the management of allergic rhinitis and comorbid gonists Clin Exp All Rev 2003; 3: 74-80 asthma. Pelikan Z, Pelikan-Filipek M. Role of nasal allergy in chronic 112. sinusitis – diagnostic value of nasal challenge with maxillary J Allergy Clin Immunol 1990; 86:484-91. allergen. Penard-Morand C, Charpin D, Raherison C, Kopferschmitt C, 113. D, Lavaud F et al. Long-term exposure to back- Caillaud air pollution related to respiratory and allergic health ground schoolchildren. Clin Exp Allergy. 2005; 35: 1279-87. in Perry TT, Corren J, Philip G, Kim EH, Conover-Walker MK, 114. MP et al. Protective effect of montelukast on lower and Malice respiratory tract responses to short-term cat allergen upper Ann Allergy Asthma Immunol 2004; 93: 431-8. exposure. Platts-Mills TAE. The Role of Allergens in Allergic Disease. J 115. Clin Immunol 1998; 101: S364-66. Allergy Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N 116. J Med. 2005 Nov 3;353(18):1934-44 Engl Plewako H, Arvidsson M, Petruson K. The effect of omalizu- 117. on nasal allergic inflammation. J Allergy Clin Immunol mab 110: 68-71. 2002; Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, 118. JE, et al. Features of airway remodeling and eosi- Tarara inflammation in chronic rhinosinusitis: is the histonophilic similar to asthma? J Allergy Clin Immunol. 2003; pathology 112:877-82. Poole MD. A focus on acute sinusitis in adults: changes in 119. management. Am J Med 1999; 106: 385-475. disease Potter PC, Van Niekerk CH, Schoeman HS. Effects of triam- 120. on quality of life in patients with persistent allergic cinolone Ann Allergy Asthma Immunol 2003; 91: 368-74. rhinitis. Potter PC. Levocetirizine is effective for symptom relief 121. nasal congestion in adolescent and adult (PAR) including to house dust mites. Allergy 2003; 58: 893-9. sensitized Practice parameters for allergen immunotherapy. Joint Task 122. on Practice Parameters, representing the American Force of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint College of Allergy, Asthma and Immunology. J Allergy Clin Council 1996; 98 (6 Pt 1): 1001-1011. Immunol Prescott CA. Nasal Obstruction in Infancy. Arch Dis Child 123. 72: 287-9. 1995; Quraishi MS, Jones NS, Mason J. The rheology of nasal mu- 124. a review. Clin Otolaryngol 1998; 23: 403-13. cus: Rachelefsky GS. National guidelines needed to manage rhini- 125. and prevent complications. Ann Allergy Asthma Immunol tis Mar; 82:296-305. 1999 Rak S, Jacobson MR, Sudderick RM. Influence of pro-longed 126. with topical corticosteroid (fluticasone propionate) treatment early and late nasal responses and celular in-filtration in on nasal mucosa after allergen challenge. Clin Exp Allergy the 24: 930-9. 1994; Ramadan HH, Fornelli R, Ortiz AO, Rodman S. Correlation of 127. and severity of sinus disease. Am J Rhinol 1999; 12: allergy 345-7. Ricketti AJ. Allergic rhinitis. In: Grammer LC, Greenberger PA 128. Patterson’s Allergic Disease, 6 (ed), th Philadelphia, Pen- ed, nsyllvania, Lippincott Williams & Wilkins, 2002, p.159-182.
Consenso Rev. bras. alerg. imunopatol. – Vol. 29, Nº 1, 2006 57 Rizzo MC, Solé D, Rizzo A, Holanda MA, Rios JB, Wandalsen 129. et al. Etiologia da Doença Atópica em Crianças Brasileiras NP, Estudo Multicêntrico. J. Pediatr. (Rio J) 1995; 71: 31-35. - Rosário Filho NA. Reflexões sobre Polinose: 20 Anos de Expe- 130. Rev Bras Alerg lmunopatol 1997; 20 (6): 210-13. riência. Sander C, Rajakulasingam K. Leukotriene receptor antago- 131. for the treatment of allergic rhinitis. Clin Exp Allergy nists 32: 4-7 2002, Sazonov Kocevar V, Thomas J 3rd, Jonsson L, Valovirta E, 132. F, et al. Association between aller-gic rhinitis and Kristensen resource use among asthmatic chil-dren in Norway. hospital 2005; 60:338-42. Allergy Scadding GK. Corticosteroids in the treatment of pediatric 133. rhinitis. J Allergy Clin Immunol 2001; 108: S59-64. allergic Scarano E. Relationship Between Chronic Nasal Obs-truction 134. Craniofacial Growth: an Experimental Model. Int J and Otorhinolaryngol 1998; 45 (2): 125-31. Pediatr Schiffman SS, Nagle HT. Effect of Environmental Pollutants 135. Taste and Smell. Otolaryngol Head Neck Surg 1992; 106: on 693-700. Settipane RA. Nonallergie Rhinitis. In: Montanaro A, Bardana 136. EJ, ed. Immunology and Allergy Clinics of North America. Jr Díagnosis of Allergic Disease - Masqueraders of Differential Philadelphia: Saunders 1996; 16: 49-67. AlIergy. Shapiro PA. Effects of Nasal Obstruction on Facial Develop- 137. J Allergy Clin lmmunol 1988; 81: 967-71. ment. Shturman-Ellstein R, Zeballos RJ, Buckley JM, Souhrada JF. 138. Beneficial Etfect of Nasal Breathing on Exercise – Indu- The Bronchoconstriction. Am Rev Respir Dis 1978; 118:65- ced 73. Silvers WS, Poole JA. Exercise-induced rhinitis: a common 139. that adversaly affects allergic and nonallergic athle- disorder Ann Allergy Asthma Immunol 2006; 96: 334-340. tes. Simon RA. Adverse Reactions to Food and Drug Additives. In: 140. A, Bardana Jr EJ, ed. Immunol Allergy Clin of Montanaro America. Differential Diagnosis of Allergic Disease Mas- North of Allergy. Philadelphia: Saunders 1996; 16: 137- queraders 176. Simons FE, Prenner BM, Finn A. Efficacy and safety of deslo- 141. in the treatment of perennial allergic rhinitis. J Allerratadine Clin Immunol 2003; 111: 617-22. gy Simons FE, Silas P, Portnoy JM, Catuogno J, Chapman D, 142. AO et al. Safety of cetirizine in infants 6 to 11 Olufade of age: a randomized, double-blind, placebo-control- months study. J Allergy Clin Immunol 2003; 111: 1244-8. led Simons FE. H1-antihistamines in children. Clin Allergy Immu- 143. 2002; 17: 437-64. nol Skinner DW, Richards SH. A comparison between sinus radio- 144. findings and macroscopic appearances of the paranagraphic sinus mucosa. Ear Nose Throat J 1991; 70:169-72. sal Skoner D, Rachelefsky G, Meltzer E, Chervinsky P, Morris R, 145. J et al. Detection of growth suppression in children Seltzer treatment with intranasal belcomethasone dipropiona- during Pediatrics 2000; 105: 23-30. te. Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji 146. The effects of intranasal triamcinolone acetonide and in- D. fluticasone propionate on short-term bone growth tranasal HPA axis in children with allergic rhinitis. Ann Allergy As- and Immunol 2003; 90: 56-62. thma Smith LF, Brindley PC. Indications, evaluations, complications 147. results of functional endoscopic sinus surgery in 200 pa- and Otolaryngol Head Neck Surg 1993;108: 688-96. tients. Solé D, Camelo-Nunes IC, Vana AT, Yamada E, Werneck F, 148. LS, et al. Prevalence of rhinitis and related-symptoms Freitas schoolchildren from different cities in Brazil. Allergol in (Madr) 2004; 32: 7-12. Immu-nopathol Solé D, Nunes ICC, Rosário NA, Freitas LS, Brito M, Melo K, 149. al. Prevalence of asthma, rhino-conjunctivitis, and atopic et among Brazilian adoles-cents. Comparison between eczema phase I and III. J Allergy Clin Immunol 2004; 113: ISAAC S283. Stahl E, Van Rompay W, Wang Ec, Thomson DM. Cost-ef- 150. analysis of budesonide aqueous nasal spray and fectiveness propionate nasal spray in the treatment of peren- fluticasone allergic rhinitis. Ann Allergy Asthma Immunol 2000; 84: nial 397-402. Stamm AC. Microcirurgia Não-Sinusal. Rio de .Janeiro: Editora 151. 1ª ed,1995. Revinter, Stammberger H, Posawetz W. Functional Endoscopie Sinus 152. Concept, Indications and Results of the Messerklin- Surgery: ger Technique. Eur Arch Otorhinolaryngol 1990; 247, 63-76. Stammberger H. Functional endoscopic sinus surgery. Phila- 153. B.C. Decker, 1991. delphia: Stankiewicz JA. Cerebrospinal Fluid Fistula and Endoscopic 154. Surgery. Laryngoscope 1991; 101: 250-256. Sinus Stankiewicz JA. Endoscopic and imaging techniques in the 155. of chronic rhinosinusitis. Curr Allergy Asthma Rep diagnosis 3: 519-22. 2003; Stevenson J, Cornah D, Evrard P, Vanderheyden V, Billard C, 156. M, et al. Long-term evaluation of the impact of the h1- Bax antagonist cetirizine on the behavioral, cognitive, receptor psychomotor development of very young children with and dermatitis. Pediatr Res 2002; 52: 251-7. atopic Stokes J, Casale TB. Rationale for new treatments aimed at 157. immunomodulation. Ann Allergy Asthma Immunol 2004: IgE 212-218. 93; Storms WWA. Comprehensive Diagnostic Approach to Upper 158. Disease. J Allergy Clin lmmunol 1998; 101: 5361-3. Airway Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, 159. HR et al. Worldwide variation in Prevalence of Anderson of Allergic Rhinoconjunnctivitis in Children: The Symptoms Study of Asthma and Allergies in Childhood International Pediatr Allergy lmmunol 1997; 8: 161-76. (ISAAC). Szczeklik A, Nizankowska E, Sanak M, Swierczynska M. Aspi- 160. induced rhinitis and asthma. Curr Allergy Clin Immunol rin 1: 27-33. 2001; Szefler SJ. Pharmacokinetics of intranasal corticosteroids. J 161. Clin Immunol 2001; 108: S26-31. Allergy Taramarcaz P, Gibson PG. Intranasal corticosteroids for asth- 162. control in people with coexisting asthma and rhinitis. Coma Database Syst Rev 2003; 4: CD003570. chrane Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma- 163. health care resource use among asthmatic children related and without concomitant allergic rhinitis. Pediatrics with 115: 129-34. 2005; Thompson AC. Surgical Reduction of the Inferior Turbinate in 164. Extended Follow-up. J Laryngol Otol 1989; 103:577- Children 579. Tobias KR, Ferriani VP, Chapman MD, Arruda LK. Exposure to 165. allergens in homes of patients with asthma and/or rhi- indoor in southeast Brazil: effect of mattress and pillow covers nitis mite allergen levels. Int Arch Allergy Immunol. 2004 Apr; on 133(4):365-70. Togias AG. Non-allergic rhinitis. In: Mygind N, Naclerio RM, 166. Allergic and non-allergic rhinitis: clinical aspects. Cope- ed. Munksgaard 1993; p.159-66. nhagen: Trittel C, Moller L, Euler HH, Werner JA. Churg-Stauss Syn- 167. A Diferencial Diagnosis in Chronic Polypoid Sinusitis. drome. 1995; 74: 577-80. Laryngorhinootologie Uri N, Cohen-Kerem R, Elmalah I, Doweck I, Greenberg E. 168. of fungal sinusitis in immunocompetent pa- Classification Otolaryngol Head Neck Surg 2003; 129: 372-8. tients. Van Adelsberg J, Philip G, Laforce CF, Weinstein SF, Menten 169. Malice MP, et al. Randomized controlled trial evaluating the J, benefit of montelukast for treating spring seasonal al- clinical rhinitis. Ann Allergy Asthma Immunol 2003;90:214-22. lergic van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, 170. GW, Durham SR et al. Consensus statement on the Canonica of allergic rhinitis. Allergy 2000; 55(2): 116-34. treatment Voegels RL. Polipose Nasal - Estudo da Correlação entre as 171. Ib, 3, 4 e 5 e a Molécula de Adesão VCAM-1 Interleucinas a Presença ou não de Alergia. São Paulo. Tese (Douto- com - Faculdade de Medicina da Universidade de São Paulo, rado) 1998. Vries JE, CaraBalli JM, Aversa G. Receptors e Cytokines lnvol- 172. in Allergic TH2 Cell Response. J Allergy Clin Immunol ved 103: 5492-6. 1999; Warner JO. A double-blinded, randomized, placebo-controlled 173. of cetirizine in preventing the onset of asthma in chil- trial with atopic dermatitis: 18 months' treatment and 18 dren post-treatment follow-up. J Allergy Clin Immunol months' 929-37. 2001;108: White M. Mediators of Inflammation and the Inflammatory 174. J AlIergy Clin Immunol 1999; 103: 5378-81. Process. Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of 175. and desloratadine on subjective and objective fexofenadine of nasal congestion in seasonal allergic rhinitis. measures Exp Allergy 2002; 32: 1504-9. Clin Wilson AM, McFarlane LC, Lipworth BJ. Effects of Repeat On- 176. Daily Dosing of Three Intranasal Corticosteroids on Basal ce Dynamic Measures on Hypotalamic-Pituitary-Adrenal-A- and xis Activity. J Allergy Clin Immunol 1998; 101: 470-4.
Page 1 and 2: 01/29 06/29bras. alerg. imunopatol.
Page 3 and 4: Consenso Rev. bras. alerg. imunopat
Page 27: Consenso Rev. bras. alerg. imunopat

Consenso - Associação Brasileira de Alergia e Imunopatologia

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?